Aug 8 |
Q2 2024 Editas Medicine Inc Earnings Call
|
Aug 7 |
Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript
|
Aug 7 |
Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates
|
Aug 7 |
Editas: Q2 Earnings Snapshot
|
Aug 7 |
Editas Medicine GAAP EPS of -$0.82 misses by $0.13, revenue of $0.51M misses by $3.63M
|
Aug 7 |
Editas Medicine Announces Second Quarter 2024 Results and Business Updates
|
Aug 6 |
Editas Medicine Q2 2024 Earnings Preview
|
Jul 31 |
Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update
|
Jul 17 |
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
|
Jul 9 |
3 Profitable CRISPR Stocks Earning Analysts’ Praise
|